🚀 VC round data is live in beta, check it out!
Stille Valuation Multiples
Discover revenue and EBITDA valuation multiples for Stille and similar public comparables like Bastide Le Confort Médical, Paragon Care, KORU Medical Systems, Tristel and more.
Stille Overview
About Stille
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
Founded
1841
HQ
Employees
147
Website
Sectors
Financials (LTM)
EV
$219M
Stille Financials
Stille reported last 12-month revenue of $66M and EBITDA of $13M.
In the same LTM period, Stille generated $34M in gross profit, $13M in EBITDA, and $7M in net income.
Revenue (LTM)
Stille P&L
In the most recent fiscal year, Stille reported revenue of $64M and EBITDA of $12M.
Stille expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $66M | XXX | $64M | XXX | XXX | XXX |
| Gross Profit | $34M | XXX | $31M | XXX | XXX | XXX |
| Gross Margin | 51% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $13M | XXX | $12M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $7M | XXX | $6M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Stille Stock Performance
Stille has current market cap of $219M, and enterprise value of $219M.
Market Cap Evolution
Stille's stock price is $24.37.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $219M | $219M | 22.6% | XXX | XXX | XXX | $0.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialStille Valuation Multiples
Stille trades at 3.3x EV/Revenue multiple, and 16.8x EV/EBITDA.
EV / Revenue (LTM)
Stille Financial Valuation Multiples
As of April 11, 2026, Stille has market cap of $219M and EV of $219M.
Equity research analysts estimate Stille's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Stille has a P/E ratio of 32.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $219M | XXX | $219M | XXX | XXX | XXX |
| EV (current) | $219M | XXX | $219M | XXX | XXX | XXX |
| EV/Revenue | 3.3x | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | 16.8x | XXX | 17.6x | XXX | XXX | XXX |
| EV/EBIT | 24.5x | XXX | 24.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.5x | XXX | 7.1x | XXX | XXX | XXX |
| P/E | 32.0x | XXX | 35.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 132.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Stille Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Stille Margins & Growth Rates
Stille's revenue in the last 12 month grew by 10%.
Stille's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Stille's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stille's rule of X is 60% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Stille Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 60% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 26% | XXX | 27% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Stille Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bastide Le Confort Médical | XXX | XXX | XXX | XXX | XXX | XXX |
| Paragon Care | XXX | XXX | XXX | XXX | XXX | XXX |
| KORU Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Tristel | XXX | XXX | XXX | XXX | XXX | XXX |
| Standard Glass Lining | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Stille M&A Activity
Stille acquired XXX companies to date.
Last acquisition by Stille was on XXXXXXXX, XXXXX. Stille acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Stille
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialStille Investment Activity
Stille invested in XXX companies to date.
Stille made its latest investment on XXXXXXXX, XXXXX. Stille invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Stille
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Stille
| When was Stille founded? | Stille was founded in 1841. |
| Where is Stille headquartered? | Stille is headquartered in Sweden. |
| How many employees does Stille have? | As of today, Stille has over 147 employees. |
| Is Stille publicly listed? | Yes, Stille is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Stille? | Stille trades under STIL ticker. |
| When did Stille go public? | Stille went public in 2005. |
| Who are competitors of Stille? | Stille main competitors are Bastide Le Confort Médical, Paragon Care, KORU Medical Systems, Tristel. |
| What is the current market cap of Stille? | Stille's current market cap is $219M. |
| What is the current revenue of Stille? | Stille's last 12 months revenue is $66M. |
| What is the current revenue growth of Stille? | Stille revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Stille? | Current revenue multiple of Stille is 3.3x. |
| Is Stille profitable? | Yes, Stille is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Stille? | Stille's last 12 months EBITDA is $13M. |
| What is Stille's EBITDA margin? | Stille's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Stille? | Current EBITDA multiple of Stille is 16.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.